During the past decade, Impact Research Institute conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Impact Research Institute" #1 sponsor was "Inventiva Pharma" with 2 trials, followed by "Eli Lilly and Company" with 1 trials sponsored, "Galectin Therapeutics Inc." with 1 trials sponsored, "Gilead Sciences" with 1 trials sponsored and "Helio Genomics" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Impact Research Institute" #1 collaborator was "Novo Nordisk A/S" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Impact Research Institute" are "NASH - Nonalcoholic Steatohepatitis" (3 trials), "Nonalcoholic Fatty Liver Disease" (2 trials), "Cirrhosis" (1 trials), "Diabetes Mellitus, Type 2" (1 trials) and "HCC" (1 trials). Many other conditions were trialed in "Impact Research Institute" in a lesser frequency.

Most popular intervention types in "Impact Research Institute" are "Drug" (7 trials), "Diagnostic Test" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "IVA337" (2 trials), "Cilofexor (CILO)/Firsocostat (FIR)" (1 trials), "Empagliflozin" (1 trials) and "Multi-analyte Blood Test" (1 trials). Other intervention names were less common.

The vast majority of trials in "Impact Research Institute" are 8 trials for "All" genders.

Currently, there are NaN active trials in "Impact Research Institute". undefined are not yet recruiting, 5 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Impact Research Institute, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Impact Research Institute, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".